Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 2/20 | 0.40 |
| ▸ | CTSK | P43235 | 2/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29989116 | 1.00 | CTSS (0.40) | CTSSCTSKCTSLALDH1A1L3MBTL1 | |
| SCHEMBL9979091 | 0.94 | CTSS (0.49) | CTSSCTSKCTSLALDH1A1L3MBTL1 | |
| SCHEMBL15330024 | 0.84 | CTSL (0.33) | CTSSCTSKCTSLALDH1A1L3MBTL1 | |
| SCHEMBL2544154 | 0.83 | CTSS (0.45) | CTSSCTSKCTSLALDH1A1L3MBTL1 | |
| SCHEMBL10383011 | 0.83 | L3MBTL1 (0.46) | ALDH1A1L3MBTL1MAPTNPSR1MAPK1 | |
| SCHEMBL18734056 | 0.80 | NAAA (0.39) | CTSSCTSKCTSLFGFR2 | |
| SCHEMBL17423613 | 0.79 | MAPK1 (0.43) | ALDH1A1L3MBTL1MAPTNPSR1MAPK1 | |
| SCHEMBL9927547 | 0.79 | SRC (0.36) | CTSSCTSKCTSLALDH1A1L3MBTL1 | |
| SCHEMBL14362901 | 0.79 | PKM (0.34) | ALDH1A1L3MBTL1MAPTLMNACYP1A2 | |
| SCHEMBL17423620 | 0.79 | MAPK1 (0.40) | CTSSCTSKCTSLALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109370609-B | Liquid crystal composition for VA-LCD (vertical alignment-liquid Crystal display) with low threshold, low power consumption, low viscosity and quick response | 河北迈尔斯通电子材料有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-107298980-B | Negative liquid crystal compound and preparation method thereof | 河北迈尔斯通电子材料有限公司 | 2020-09-22 | — | — | CN | disclosed |
| CN-107779203-B | Liquid crystal composition with low threshold and low power consumption for VA-LCD | 河北迈尔斯通电子材料有限公司 | 2020-02-21 | — | — | CN | disclosed |
| US-9790427-B2 | Liquid crystal compound having a 3,6-dihydro-2H-pyran ring, negative dielectric anisotropy, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20160230094-A1 | LIQUID CRYSTAL COMPOUND HAVING A 3,6-DIHYDRO-2H-PYRAN RING, NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-08-11 | — | — | US | disclosed |
| US-8580146-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| US-8580146-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| US-20120193577-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-08-02 | — | — | US | disclosed |
| US-7291368-B2 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2007-11-06 | — | — | US | disclosed |
| US-7291368-B2 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2007-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160230094-A1 | LIQUID CRYSTAL COMPOUND HAVING A 3,6-DIHYDRO-2H-PYRAN RING, NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | DRD1, ZKSCAN2, ZRANB2 | CTSS 4026/4885CTSK 3931/4885CTSL 3930/4885 |
| US-20120193577-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | KIF23, MARK3, CCND3 | CTSS 2841/4885CTSK 1918/4885CTSL 4048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.